🔎 Trials Near Me

Почетна › Рак бешике › Džordžija

Kliničke studije za Рак бешике u državi Džordžija

19 studija za Рак бешике traži učesnike na lokacijama u državi Džordžija.

Gradovi u državi Džordžija

Zvanični tekst studije (na engleskom)

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382

BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy

  • Central Georgia Cancer Center, Macon
  • Central Georgia Cancer Center, Macon
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07869836

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

  • Emory University Hospital ( Site 0824), Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2026. · NCT07419295

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

  • Grady Health System, Atlanta
  • Emory Proton Therapy Center, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT06770582

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

  • Emory University Hospital Midtown, Atlanta
  • Emory Children's Center, Atlanta
  • Emory University Hospital, Atlanta
  • и још 1
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07206225

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • Emory University, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06465069

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Northeast Georgia Medical Center Braselton, Braselton
  • Atlanta VA Medical Center, Decatur
  • Northeast Georgia Medical Center-Gainesville, Gainesville
  • и још 4
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

  • Emory University Hospital, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT05614739

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

  • CTCA at Southeastern Regional Medical Center, Newnan
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07061964

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 23. 10. 2026. · NCT07097142

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

  • Tennessee Oncology, PLLC- Ringgold, Ringgold
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 8. 10. 2026. · NCT07421700

Measuring Surgical Recovery After Radical Cystectomy

  • Emory University, Atlanta
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT03193970

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

  • Urology of Greater Atlanta - Sandy Springs, Atlanta
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07480356

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

  • The Winship Cancer Institute Emory University, Atlanta
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 15. 9. 2026. · NCT07217171

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

  • Emory University, Atlanta
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 9. 2026. · NCT06567743

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

  • Emory University, Atlanta
  • Georgia Cancer Center at Augusta University, Augusta
Тражи се учесникФаза 1/2
Узраст 18 и старији · Оба пола · Ажурирано 7. 8. 2026. · NCT04752722

Enfortumab Vedotin Plus Pembrolizumab for the Treatment of Locally Advanced or Metastatic Bladder Cancer of Variant Histology

  • Grady Health System, Atlanta
  • Emory University Hospital Midtown, Atlanta
  • Emory University Hospital/Winship Cancer Institute, Atlanta
  • и још 1
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 29. 7. 2026. · NCT05756569

Blue Light Cystoscopy With Cysview® Registry

  • Emory University School of Medicine, Atlanta
Тражи се учесникОпсервациона студија
Узраст 18 и старији · Оба пола · Ажурирано 18. 12. 2025. · NCT02660645

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Atlanta
  • Massive Bio SYNERGY-AI site, Savannah
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.